Table of Contents
ISRN Hepatology
Volume 2014 (2014), Article ID 828074, 13 pages
Review Article

Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives

1Laboratory of Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain
2National Institute of Health Carlos III, CIBERehd, 28029 Madrid, Spain
3Department of Physiology and Pharmacology, Campus Miguel de Unamuno E.D. B-17, University of Salamanca, 37007 Salamanca, Spain

Received 5 December 2013; Accepted 2 January 2014; Published 16 February 2014

Academic Editors: S. DeMorrow, M. G. Mancino, and S. Pinlaor

Copyright © 2014 Rocio I. R. Macias. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rocio I. R. Macias, “Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives,” ISRN Hepatology, vol. 2014, Article ID 828074, 13 pages, 2014. doi:10.1155/2014/828074